Sun Pharma and Takeda sign agreement to introduce Voltapraz in India 0 21.06.2024 08:30 Thehindubusinessline.com The agreement grants Sun Pharma non-exclusive patent licensing rights to market Vonoprazan tablets, available in 10 mg and 20 mg dosages, in India Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
